MedWatch

AJ Vaccines upgrades for DKK 300 million

In order to ramp up production of its new polio vaccine, AJ Vaccines has invested DKK 300 million (EUR 40 million) in upgrading existing production facilities in Copenhagen.

CEO Klaus Hermansen (to the left) and AJ Vaccines team at the signing of a partnership deal earlier this year for a new meningitis vaccine. | Foto: AJ Vaccines PR

A large construction project is being prepared at the Serum Institute campus in Copenhagen. The project will extend over the next six months.

AJ Vaccines purchased the State Serum Institute's vaccine production and has recently invested around DKK 300 million (EUR 30 million) in order to upgrade production facilities. The expanded facility will be used to produce the company's new polio vaccine, says AJ Vaccines CEO Klaus Hermansen in an interview with MedWatch.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier